Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effect of a New Formulation of Torasemide (Prolonged Release)on Myocardial Fibrosis in Patients With Heart Failure. (TORAFIC)

This study has been completed.
Information provided by:
Ferrer Internacional S.A. Identifier:
First received: December 11, 2006
Last updated: July 14, 2009
Last verified: June 2009